IL93041A - 3-) 1,2,5,6-Tetrahydropyrid-4 il (- H1 Pyrolopyridines and medicinal preparations containing them - Google Patents

3-) 1,2,5,6-Tetrahydropyrid-4 il (- H1 Pyrolopyridines and medicinal preparations containing them

Info

Publication number: IL93041A
Authority: IL; Israel
Prior art keywords: pyrrolo; pyridine; tetrahydropyrid; hydrogen; nmr
Prior art date: 1989-01-20

Application number

IL9304190A

Other languages

English (en)

Hebrew (he)

Other versions

IL93041A0 (en

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-01-20

Filing date

1990-01-12

Publication date

1994-02-27

1990-01-12 Application filed by Pfizer filed Critical Pfizer

1990-11-05 Publication of IL93041A0 publication Critical patent/IL93041A0/xx

1994-02-27 Publication of IL93041A publication Critical patent/IL93041A/en

Links

239000008194 pharmaceutical composition Substances 0.000 title claims description 7
UTZWZATUUDPCFB-UHFFFAOYSA-N 3-(1,2,3,6-tetrahydropyridin-4-yl)-1h-pyrrolo[3,2-b]pyridine Chemical class C1NCCC(C=2C3=NC=CC=C3NC=2)=C1 UTZWZATUUDPCFB-UHFFFAOYSA-N 0.000 title claims 2
150000003839 salts Chemical class 0.000 claims abstract description 16
125000000217 alkyl group Chemical group 0.000 claims abstract description 10
125000003545 alkoxy group Chemical group 0.000 claims abstract description 6
125000001589 carboacyl group Chemical group 0.000 claims abstract description 3
229910052736 halogen Inorganic materials 0.000 claims abstract 2
150000002367 halogens Chemical class 0.000 claims abstract 2
150000001875 compounds Chemical class 0.000 claims description 61
239000000203 mixture Substances 0.000 claims description 37
-1 phenyloxy Chemical group 0.000 claims description 31
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 28
229910052739 hydrogen Inorganic materials 0.000 claims description 22
239000001257 hydrogen Substances 0.000 claims description 22
229910052757 nitrogen Inorganic materials 0.000 claims description 17
DRTQHJPVMGBUCF-UCVXFZOQSA-N 1-[(2s,3s,4s,5s)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione Chemical compound O[C@H]1[C@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UCVXFZOQSA-N 0.000 claims description 12
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 12
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 5
125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 5
PJYVGMRFPFNZCT-UHFFFAOYSA-N 3-(1,2,3,6-tetrahydropyridin-4-yl)-1,4-dihydropyrrolo[3,2-b]pyridin-5-one Chemical compound C1=2NC(=O)C=CC=2NC=C1C1=CCNCC1 PJYVGMRFPFNZCT-UHFFFAOYSA-N 0.000 claims description 4
KWQWBZIGHIOKIO-UHFFFAOYSA-N 5-propoxy-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-pyrrolo[3,2-b]pyridine Chemical compound C12=NC(OCCC)=CC=C2NC=C1C1=CCNCC1 KWQWBZIGHIOKIO-UHFFFAOYSA-N 0.000 claims description 4
208000008589 Obesity Diseases 0.000 claims description 4
230000016571 aggressive behavior Effects 0.000 claims description 4
125000004122 cyclic group Chemical group 0.000 claims description 4
235000020824 obesity Nutrition 0.000 claims description 4
CILLFDCHNZEIGM-UHFFFAOYSA-N 5-propan-2-yloxy-3-(1,2,3,6-tetrahydropyridin-4-yl)-1h-pyrrolo[3,2-b]pyridine Chemical compound C12=NC(OC(C)C)=CC=C2NC=C1C1=CCNCC1 CILLFDCHNZEIGM-UHFFFAOYSA-N 0.000 claims description 3
230000001430 anti-depressive effect Effects 0.000 claims description 3
208000024891 symptom Diseases 0.000 claims description 3
WIHXNJLRQMHBFE-UHFFFAOYSA-N 3-(1,2,3,6-tetrahydropyridin-4-yl)-1h-pyrrolo[2,3-c]pyridine Chemical compound C1NCCC(C=2C3=CC=NC=C3NC=2)=C1 WIHXNJLRQMHBFE-UHFFFAOYSA-N 0.000 claims description 2
ABSVAQCGVZCXOI-UHFFFAOYSA-N 5-cyclopentyloxy-3-(1,2,3,6-tetrahydropyridin-4-yl)-1h-pyrrolo[3,2-b]pyridine Chemical compound C1CCCC1OC1=CC=C(NC=C2C=3CCNCC=3)C2=N1 ABSVAQCGVZCXOI-UHFFFAOYSA-N 0.000 claims description 2
239000000935 antidepressant agent Substances 0.000 claims description 2
OQDGBIQQFFTLKL-UHFFFAOYSA-N 3-(1,2,3,6-tetrahydropyridin-4-yl)-1h-pyrrolo[2,3-b]pyridine Chemical compound C1NCCC(C=2C3=CC=CN=C3NC=2)=C1 OQDGBIQQFFTLKL-UHFFFAOYSA-N 0.000 claims 1
JPZXYOVLOYJXAV-UHFFFAOYSA-N 5-[(2-methylpropan-2-yl)oxy]-3-(1,2,3,6-tetrahydropyridin-4-yl)-1h-pyrrolo[3,2-b]pyridine Chemical compound C12=NC(OC(C)(C)C)=CC=C2NC=C1C1=CCNCC1 JPZXYOVLOYJXAV-UHFFFAOYSA-N 0.000 claims 1
OQCCIRJNHWTROW-UHFFFAOYSA-N 5-butoxy-3-(1,2,3,6-tetrahydropyridin-4-yl)-1h-pyrrolo[3,2-b]pyridine Chemical compound C12=NC(OCCCC)=CC=C2NC=C1C1=CCNCC1 OQCCIRJNHWTROW-UHFFFAOYSA-N 0.000 claims 1
MQTZUWUYJPCZID-UHFFFAOYSA-N 5-chloro-3-(1,2,3,6-tetrahydropyridin-4-yl)-1h-pyrrolo[3,2-b]pyridine Chemical compound C12=NC(Cl)=CC=C2NC=C1C1=CCNCC1 MQTZUWUYJPCZID-UHFFFAOYSA-N 0.000 claims 1
RBFMRHDBVILZMO-UHFFFAOYSA-N 5-ethoxy-3-(1,2,3,6-tetrahydropyridin-4-yl)-1h-pyrrolo[3,2-b]pyridine Chemical compound C12=NC(OCC)=CC=C2NC=C1C1=CCNCC1 RBFMRHDBVILZMO-UHFFFAOYSA-N 0.000 claims 1
GSVMOOFAJGTVAZ-UHFFFAOYSA-N 5-methyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1h-pyrrolo[3,2-b]pyridine Chemical compound C12=NC(C)=CC=C2NC=C1C1=CCNCC1 GSVMOOFAJGTVAZ-UHFFFAOYSA-N 0.000 claims 1
SNJLSZVIOFJOIE-UHFFFAOYSA-N 5-phenylmethoxy-3-(1,2,3,6-tetrahydropyridin-4-yl)-1h-pyrrolo[3,2-b]pyridine Chemical compound C=1C=CC=CC=1COC(N=C12)=CC=C1NC=C2C1=CCNCC1 SNJLSZVIOFJOIE-UHFFFAOYSA-N 0.000 claims 1
239000004480 active ingredient Substances 0.000 claims 1
230000002539 anti-aggressive effect Effects 0.000 claims 1
230000003579 anti-obesity Effects 0.000 claims 1
125000004429 atom Chemical group 0.000 claims 1
125000004093 cyano group Chemical group *C#N 0.000 claims 1
125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
GXTMDNJITXSIRL-UHFFFAOYSA-N n,n-dimethyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1h-pyrrolo[3,2-b]pyridin-5-amine Chemical compound C12=NC(N(C)C)=CC=C2NC=C1C1=CCNCC1 GXTMDNJITXSIRL-UHFFFAOYSA-N 0.000 claims 1
MTXPFWNUKVMJLO-UHFFFAOYSA-N 3-(3,6-dihydro-2h-pyridin-1-yl)-1h-pyrrolo[3,2-b]pyridine Chemical compound C1C=CCCN1C1=CNC2=CC=CN=C12 MTXPFWNUKVMJLO-UHFFFAOYSA-N 0.000 abstract 1
239000000543 intermediate Substances 0.000 abstract 1
125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 abstract 1
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 96
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 84
239000007787 solid Substances 0.000 description 59
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 58
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 49
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 45
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 38
239000000243 solution Substances 0.000 description 37
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 33
238000005481 NMR spectroscopy Methods 0.000 description 32
238000010828 elution Methods 0.000 description 28
239000003921 oil Substances 0.000 description 27
235000019198 oils Nutrition 0.000 description 27
239000000741 silica gel Substances 0.000 description 27
229910002027 silica gel Inorganic materials 0.000 description 27
238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 26
101150041968 CDC13 gene Proteins 0.000 description 25
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 25
HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 25
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 24
229940093499 ethyl acetate Drugs 0.000 description 19
235000019439 ethyl acetate Nutrition 0.000 description 19
230000035484 reaction time Effects 0.000 description 19
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 19
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 17
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
238000006243 chemical reaction Methods 0.000 description 15
239000000284 extract Substances 0.000 description 15
238000003818 flash chromatography Methods 0.000 description 15
229940086542 triethylamine Drugs 0.000 description 15
239000000706 filtrate Substances 0.000 description 14
238000000605 extraction Methods 0.000 description 12
239000011541 reaction mixture Substances 0.000 description 12
239000002904 solvent Substances 0.000 description 12
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 11
239000012298 atmosphere Substances 0.000 description 10
238000005160 1H NMR spectroscopy Methods 0.000 description 9
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 9
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 9
239000002585 base Substances 0.000 description 9
239000007810 chemical reaction solvent Substances 0.000 description 7
238000010992 reflux Methods 0.000 description 7
YUGDKEWUYZXXRU-UHFFFAOYSA-N 2-(4-chlorophenoxy)acetonitrile Chemical compound ClC1=CC=C(OCC#N)C=C1 YUGDKEWUYZXXRU-UHFFFAOYSA-N 0.000 description 6
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
239000007868 Raney catalyst Substances 0.000 description 6
NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 6
229910000564 Raney nickel Inorganic materials 0.000 description 6
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
229960000583 acetic acid Drugs 0.000 description 6
239000000843 powder Substances 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
SHAHPWSYJFYMRX-GDLCADMTSA-N (2S)-2-(4-{[(1R,2S)-2-hydroxycyclopentyl]methyl}phenyl)propanoic acid Chemical compound C1=CC([C@@H](C(O)=O)C)=CC=C1C[C@@H]1[C@@H](O)CCC1 SHAHPWSYJFYMRX-GDLCADMTSA-N 0.000 description 5
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 5
239000006260 foam Substances 0.000 description 5
238000000034 method Methods 0.000 description 5
LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical group [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 5
RBMWKMUXNBCUPZ-UHFFFAOYSA-N 5-phenylmethoxy-1h-pyrrolo[3,2-b]pyridine Chemical compound C=1C=C2NC=CC2=NC=1OCC1=CC=CC=C1 RBMWKMUXNBCUPZ-UHFFFAOYSA-N 0.000 description 4
IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 4
241001465754 Metazoa Species 0.000 description 4
WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Substances CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 4
XTXUDUUPOZHIMK-UHFFFAOYSA-N n,n-dimethyl-1h-pyrrolo[3,2-b]pyridin-5-amine Chemical compound CN(C)C1=CC=C2NC=CC2=N1 XTXUDUUPOZHIMK-UHFFFAOYSA-N 0.000 description 4
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
239000011734 sodium Substances 0.000 description 4
FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
238000001665 trituration Methods 0.000 description 4
MKYZUGYKWHDLJJ-UHFFFAOYSA-N 5-butoxy-1h-pyrrolo[3,2-b]pyridine Chemical compound CCCCOC1=CC=C2NC=CC2=N1 MKYZUGYKWHDLJJ-UHFFFAOYSA-N 0.000 description 3
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
239000005909 Kieselgur Substances 0.000 description 3
241000699670 Mus sp. Species 0.000 description 3
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
239000003054 catalyst Substances 0.000 description 3
229940125782 compound 2 Drugs 0.000 description 3
235000014113 dietary fatty acids Nutrition 0.000 description 3
239000000194 fatty acid Substances 0.000 description 3
229930195729 fatty acid Natural products 0.000 description 3
150000002689 maleic acids Chemical class 0.000 description 3
239000011591 potassium Substances 0.000 description 3
229910052700 potassium Inorganic materials 0.000 description 3
239000002002 slurry Substances 0.000 description 3
229910052708 sodium Inorganic materials 0.000 description 3
229910000029 sodium carbonate Inorganic materials 0.000 description 3
FANCTJAFZSYTIS-IQUVVAJASA-N (1r,3s,5z)-5-[(2e)-2-[(1r,3as,7ar)-7a-methyl-1-[(2r)-4-(phenylsulfonimidoyl)butan-2-yl]-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol Chemical compound C([C@@H](C)[C@@H]1[C@]2(CCCC(/[C@@H]2CC1)=C\C=C\1C([C@@H](O)C[C@H](O)C/1)=C)C)CS(=N)(=O)C1=CC=CC=C1 FANCTJAFZSYTIS-IQUVVAJASA-N 0.000 description 2
VUDZSIYXZUYWSC-DBRKOABJSA-N (4r)-1-[(2r,4r,5r)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one Chemical compound FC1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)N[C@H](O)CC1 VUDZSIYXZUYWSC-DBRKOABJSA-N 0.000 description 2
YAUFQXZEUFCKAT-UHFFFAOYSA-N 2-(6-methyl-3-nitropyridin-2-yl)acetonitrile Chemical compound CC1=CC=C([N+]([O-])=O)C(CC#N)=N1 YAUFQXZEUFCKAT-UHFFFAOYSA-N 0.000 description 2
KKKJYDOHVKIIQP-UHFFFAOYSA-N 2-[4-(3-chlorobenzoyl)phenoxy]-N-pyridin-3-ylacetamide Chemical compound ClC=1C=C(C(=O)C2=CC=C(OCC(=O)NC=3C=NC=CC=3)C=C2)C=CC=1 KKKJYDOHVKIIQP-UHFFFAOYSA-N 0.000 description 2
JXNJQUZHZOZWMK-UHFFFAOYSA-N 2-[6-(dimethylamino)-3-nitropyridin-2-yl]acetonitrile Chemical compound CN(C)C1=CC=C([N+]([O-])=O)C(CC#N)=N1 JXNJQUZHZOZWMK-UHFFFAOYSA-N 0.000 description 2
LHASZEBEQGPCFM-CJFMBICVSA-N 2-amino-4-[(1r)-1-[[(6r)-6-[(5-chloro-2-methoxyphenyl)methyl]-7-oxo-3-(phenoxyamino)-5,6-dihydro-2h-1,4-diazepine-1-carbonyl]amino]propyl]benzoic acid Chemical compound C([C@@H]1CNC(CN(C1=O)C(=O)N[C@H](CC)C=1C=C(N)C(C(O)=O)=CC=1)=NOC=1C=CC=CC=1)C1=CC(Cl)=CC=C1OC LHASZEBEQGPCFM-CJFMBICVSA-N 0.000 description 2
HWZUMEVIIGNXGM-UHFFFAOYSA-N 2-chloro-4-methyl-5-nitropyridine Chemical compound CC1=CC(Cl)=NC=C1[N+]([O-])=O HWZUMEVIIGNXGM-UHFFFAOYSA-N 0.000 description 2
DJNQRLCFAHKFLZ-UHFFFAOYSA-N 2-methoxy-4-methyl-5-nitropyridine Chemical compound COC1=CC(C)=C([N+]([O-])=O)C=N1 DJNQRLCFAHKFLZ-UHFFFAOYSA-N 0.000 description 2
MWDVCHRYCKXEBY-LBPRGKRZSA-N 3-chloro-n-[2-oxo-2-[[(1s)-1-phenylethyl]amino]ethyl]benzamide Chemical compound N([C@@H](C)C=1C=CC=CC=1)C(=O)CNC(=O)C1=CC=CC(Cl)=C1 MWDVCHRYCKXEBY-LBPRGKRZSA-N 0.000 description 2
OVDGUTHABMXVMI-UHFFFAOYSA-N 3-nitro-4-(propylamino)benzoic acid Chemical compound CCCNC1=CC=C(C(O)=O)C=C1[N+]([O-])=O OVDGUTHABMXVMI-UHFFFAOYSA-N 0.000 description 2
AIEHUZHKFUNHCJ-UHFFFAOYSA-N 4-methyl-5-nitro-1h-pyridin-2-one Chemical compound CC1=CC(O)=NC=C1[N+]([O-])=O AIEHUZHKFUNHCJ-UHFFFAOYSA-N 0.000 description 2
ZTLPHDKBDBRZER-UHFFFAOYSA-N 5-[(2-methylpropan-2-yl)oxy]-1h-pyrrolo[3,2-b]pyridine Chemical compound CC(C)(C)OC1=CC=C2NC=CC2=N1 ZTLPHDKBDBRZER-UHFFFAOYSA-N 0.000 description 2
JEFWZYJBMYCTNP-UHFFFAOYSA-N 5-ethoxy-1h-pyrrolo[3,2-b]pyridine Chemical compound CCOC1=CC=C2NC=CC2=N1 JEFWZYJBMYCTNP-UHFFFAOYSA-N 0.000 description 2
WGRRBPXKOSKCJO-UHFFFAOYSA-N 5-methyl-1h-pyrrolo[3,2-b]pyridine Chemical compound CC1=CC=C2NC=CC2=N1 WGRRBPXKOSKCJO-UHFFFAOYSA-N 0.000 description 2
LDIOUQIXNSSOGU-UHFFFAOYSA-N 8-(3-pentylamino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5h-cyclopenta[d]pyrazolo[1,5-a]pyrimidine Chemical compound CC1=NN2C(NC(CC)CC)=C3CCCC3=NC2=C1C1=CC=C(OC)C=C1Cl LDIOUQIXNSSOGU-UHFFFAOYSA-N 0.000 description 2
VADOZMZXXRBXNY-UHFFFAOYSA-N 8-cyclopentyl-2-[4-(4-methylpiperazin-1-yl)anilino]-7-oxopyrido[2,3-d]pyrimidine-6-carbonitrile Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC1=NC=C(C=C(C#N)C(=O)N2C3CCCC3)C2=N1 VADOZMZXXRBXNY-UHFFFAOYSA-N 0.000 description 2
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical group [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
229920002472 Starch Polymers 0.000 description 2
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
229930006000 Sucrose Natural products 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
239000002253 acid Substances 0.000 description 2
230000003474 anti-emetic effect Effects 0.000 description 2
230000000648 anti-parkinson Effects 0.000 description 2
239000002111 antiemetic agent Substances 0.000 description 2
239000000939 antiparkinson agent Substances 0.000 description 2
230000037396 body weight Effects 0.000 description 2
OSVHLUXLWQLPIY-KBAYOESNSA-N butyl 2-[(6aR,9R,10aR)-1-hydroxy-9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-3-yl]-2-methylpropanoate Chemical compound C(CCC)OC(C(C)(C)C1=CC(=C2[C@H]3[C@H](C(OC2=C1)(C)C)CC[C@H](C3)CO)O)=O OSVHLUXLWQLPIY-KBAYOESNSA-N 0.000 description 2
OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
239000001768 carboxy methyl cellulose Substances 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
238000004440 column chromatography Methods 0.000 description 2
229940125801 compound 7f Drugs 0.000 description 2
238000002425 crystallisation Methods 0.000 description 2
230000008025 crystallization Effects 0.000 description 2
239000003814 drug Substances 0.000 description 2
229940079593 drug Drugs 0.000 description 2
238000001704 evaporation Methods 0.000 description 2
230000008020 evaporation Effects 0.000 description 2
239000010410 layer Substances 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
229910052943 magnesium sulfate Inorganic materials 0.000 description 2
150000002688 maleic acid derivatives Chemical class 0.000 description 2
229910052751 metal Inorganic materials 0.000 description 2
239000002184 metal Substances 0.000 description 2
PSBGROLQRNSAMY-UHFFFAOYSA-N n-(3-chlorophenyl)-4-methyl-3-(2-pyrazolo[1,5-a]pyrimidin-6-ylethynyl)benzamide Chemical compound C1=C(C#CC2=CN3N=CC=C3N=C2)C(C)=CC=C1C(=O)NC1=CC=CC(Cl)=C1 PSBGROLQRNSAMY-UHFFFAOYSA-N 0.000 description 2
HBEDNENASUYMPO-LJQANCHMSA-N n-hydroxy-4-[[(2r)-3-oxo-2-(thiophen-2-ylmethyl)-2,4-dihydroquinoxalin-1-yl]methyl]benzamide Chemical compound C1=CC(C(=O)NO)=CC=C1CN1C2=CC=CC=C2NC(=O)[C@H]1CC1=CC=CS1 HBEDNENASUYMPO-LJQANCHMSA-N 0.000 description 2
239000012044 organic layer Substances 0.000 description 2
239000000546 pharmaceutical excipient Substances 0.000 description 2
230000000704 physical effect Effects 0.000 description 2
239000011369 resultant mixture Substances 0.000 description 2
239000012047 saturated solution Substances 0.000 description 2
229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
235000017557 sodium bicarbonate Nutrition 0.000 description 2
229910000104 sodium hydride Inorganic materials 0.000 description 2
230000003595 spectral effect Effects 0.000 description 2
239000008107 starch Substances 0.000 description 2
235000019698 starch Nutrition 0.000 description 2
239000005720 sucrose Substances 0.000 description 2
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
HBENZIXOGRCSQN-VQWWACLZSA-N (1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylpentan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol Chemical compound N1([C@@H]2CC=3C4=C(C(=CC=3)O)O[C@H]3[C@@]5(OC)CC[C@@]2([C@@]43CC1)C[C@@H]5[C@](C)(O)C(C)(C)CC)CC1CC1 HBENZIXOGRCSQN-VQWWACLZSA-N 0.000 description 1
QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
FSHSBDMOHYYHRB-UHFFFAOYSA-N 1,4-dihydropyrrolo[3,2-b]pyridin-5-one Chemical compound N1C(=O)C=CC2=C1C=CN2 FSHSBDMOHYYHRB-UHFFFAOYSA-N 0.000 description 1
CXUCKELNYMZTRT-UHFFFAOYSA-N 1-Ethyl-2-benzimidazolinone Chemical compound C1=CC=C2NC(=O)N(CC)C2=C1 CXUCKELNYMZTRT-UHFFFAOYSA-N 0.000 description 1
XWIYUCRMWCHYJR-UHFFFAOYSA-N 1h-pyrrolo[3,2-b]pyridine Chemical compound C1=CC=C2NC=CC2=N1 XWIYUCRMWCHYJR-UHFFFAOYSA-N 0.000 description 1
SRSKXJVMVSSSHB-UHFFFAOYSA-N 1h-pyrrolo[3,2-c]pyridine Chemical compound N1=CC=C2NC=CC2=C1 SRSKXJVMVSSSHB-UHFFFAOYSA-N 0.000 description 1
SHCWQWRTKPNTEM-UHFFFAOYSA-N 2,6-dichloro-3-nitropyridine Chemical compound [O-][N+](=O)C1=CC=C(Cl)N=C1Cl SHCWQWRTKPNTEM-UHFFFAOYSA-N 0.000 description 1
AEYHIZZYMFAUNU-UHFFFAOYSA-N 2-(3,4-dihydro-2h-pyridin-1-yl)-1h-indole Chemical class C1CCC=CN1C1=CC2=CC=CC=C2N1 AEYHIZZYMFAUNU-UHFFFAOYSA-N 0.000 description 1
OGTHCIVCSUBYSS-UHFFFAOYSA-N 2-(3-nitro-6-phenylmethoxypyridin-2-yl)acetonitrile Chemical compound N1=C(CC#N)C([N+](=O)[O-])=CC=C1OCC1=CC=CC=C1 OGTHCIVCSUBYSS-UHFFFAOYSA-N 0.000 description 1
NIHRMLSCZMXNEW-UHFFFAOYSA-N 2-(3-nitro-6-propan-2-yloxypyridin-2-yl)acetonitrile Chemical compound CC(C)OC1=CC=C([N+]([O-])=O)C(CC#N)=N1 NIHRMLSCZMXNEW-UHFFFAOYSA-N 0.000 description 1
VWQYUNFEEYPSFJ-UHFFFAOYSA-N 2-(6-chloro-3-nitropyridin-2-yl)acetonitrile Chemical compound [O-][N+](=O)C1=CC=C(Cl)N=C1CC#N VWQYUNFEEYPSFJ-UHFFFAOYSA-N 0.000 description 1
BAZVFQBTJPBRTJ-UHFFFAOYSA-N 2-chloro-5-nitropyridine Chemical compound [O-][N+](=O)C1=CC=C(Cl)N=C1 BAZVFQBTJPBRTJ-UHFFFAOYSA-N 0.000 description 1
HNQZRUDJRPSFAU-UHFFFAOYSA-N 2-piperidin-1-yl-1h-indole Chemical class C1CCCCN1C1=CC2=CC=CC=C2N1 HNQZRUDJRPSFAU-UHFFFAOYSA-N 0.000 description 1
125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
BOPZDXATCGECMU-UHFFFAOYSA-N 4-n-[2-(4-aminoanilino)ethyl]benzene-1,4-diamine Chemical compound C1=CC(N)=CC=C1NCCNC1=CC=C(N)C=C1 BOPZDXATCGECMU-UHFFFAOYSA-N 0.000 description 1
RFPQVCYUKAYKEG-UHFFFAOYSA-N 5-chloro-1h-pyrrolo[3,2-b]pyridine Chemical compound ClC1=CC=C2NC=CC2=N1 RFPQVCYUKAYKEG-UHFFFAOYSA-N 0.000 description 1
BAAXUGBHJLVZSO-UHFFFAOYSA-N 5-methoxy-3-(1,2,3,6-tetrahydropyridin-4-yl)-1h-pyrrolo[3,2-b]pyridine Chemical compound C12=NC(OC)=CC=C2NC=C1C1=CCNCC1 BAAXUGBHJLVZSO-UHFFFAOYSA-N 0.000 description 1
LDSNUJNCJUGMKS-UHFFFAOYSA-N 5-nitro-2-phenylmethoxypyridine Chemical compound N1=CC([N+](=O)[O-])=CC=C1OCC1=CC=CC=C1 LDSNUJNCJUGMKS-UHFFFAOYSA-N 0.000 description 1
NQBFACBGCRDMCA-UHFFFAOYSA-N 5-propan-2-yloxy-1h-pyrrolo[3,2-b]pyridine Chemical compound CC(C)OC1=CC=C2NC=CC2=N1 NQBFACBGCRDMCA-UHFFFAOYSA-N 0.000 description 1
KBCPCVIDVGHFDA-UHFFFAOYSA-N 5-propoxy-1h-pyrrolo[3,2-b]pyridine Chemical compound CCCOC1=CC=C2NC=CC2=N1 KBCPCVIDVGHFDA-UHFFFAOYSA-N 0.000 description 1
244000215068 Acacia senegal Species 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
229920000084 Gum arabic Polymers 0.000 description 1
CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
238000005684 Liebig rearrangement reaction Methods 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
ZSXGLVDWWRXATF-UHFFFAOYSA-N N,N-dimethylformamide dimethyl acetal Chemical compound COC(OC)N(C)C ZSXGLVDWWRXATF-UHFFFAOYSA-N 0.000 description 1
TZYWCYJVHRLUCT-VABKMULXSA-N N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal Chemical compound CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1 TZYWCYJVHRLUCT-VABKMULXSA-N 0.000 description 1
235000019502 Orange oil Nutrition 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
244000299461 Theobroma cacao Species 0.000 description 1
235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
239000000205 acacia gum Substances 0.000 description 1
235000010489 acacia gum Nutrition 0.000 description 1
150000001242 acetic acid derivatives Chemical class 0.000 description 1
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
239000013543 active substance Substances 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
150000004791 alkyl magnesium halides Chemical class 0.000 description 1
PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
229940005513 antidepressants Drugs 0.000 description 1
239000006286 aqueous extract Substances 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical class OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
244000309464 bull Species 0.000 description 1
235000014121 butter Nutrition 0.000 description 1
235000001046 cacaotero Nutrition 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
229910000019 calcium carbonate Inorganic materials 0.000 description 1
235000010216 calcium carbonate Nutrition 0.000 description 1
235000011132 calcium sulphate Nutrition 0.000 description 1
239000002775 capsule Substances 0.000 description 1
235000011089 carbon dioxide Nutrition 0.000 description 1
235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
229940105329 carboxymethylcellulose Drugs 0.000 description 1
235000013339 cereals Nutrition 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
150000001860 citric acid derivatives Chemical class 0.000 description 1
229940125898 compound 5 Drugs 0.000 description 1
238000001816 cooling Methods 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
229910052805 deuterium Inorganic materials 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
201000010099 disease Diseases 0.000 description 1
CLPHAYNBNTVRDI-UHFFFAOYSA-N ditert-butyl propanedioate Chemical compound CC(C)(C)OC(=O)CC(=O)OC(C)(C)C CLPHAYNBNTVRDI-UHFFFAOYSA-N 0.000 description 1
239000008298 dragée Substances 0.000 description 1
230000000694 effects Effects 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
ZIUSEGSNTOUIPT-UHFFFAOYSA-N ethyl 2-cyanoacetate Chemical compound CCOC(=O)CC#N ZIUSEGSNTOUIPT-UHFFFAOYSA-N 0.000 description 1
238000009472 formulation Methods 0.000 description 1
239000012458 free base Substances 0.000 description 1
VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical class [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
239000012362 glacial acetic acid Substances 0.000 description 1
239000011521 glass Substances 0.000 description 1
239000008103 glucose Substances 0.000 description 1
239000008187 granular material Substances 0.000 description 1
150000003840 hydrochlorides Chemical class 0.000 description 1
150000002431 hydrogen Chemical class 0.000 description 1
239000001863 hydroxypropyl cellulose Substances 0.000 description 1
235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
229940071676 hydroxypropylcellulose Drugs 0.000 description 1
239000012442 inert solvent Substances 0.000 description 1
229910010272 inorganic material Inorganic materials 0.000 description 1
239000011147 inorganic material Substances 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
238000002955 isolation Methods 0.000 description 1
150000003893 lactate salts Chemical class 0.000 description 1
239000008101 lactose Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
239000011976 maleic acid Substances 0.000 description 1
150000004701 malic acid derivatives Chemical class 0.000 description 1
150000002690 malonic acid derivatives Chemical class 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
AFVFQIVMOAPDHO-UHFFFAOYSA-M methanesulfonate group Chemical class CS(=O)(=O)[O-] AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
239000011707 mineral Substances 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
UCAOGXRUJFKQAP-UHFFFAOYSA-N n,n-dimethyl-5-nitropyridin-2-amine Chemical compound CN(C)C1=CC=C([N+]([O-])=O)C=N1 UCAOGXRUJFKQAP-UHFFFAOYSA-N 0.000 description 1
GVOISEJVFFIGQE-YCZSINBZSA-N n-[(1r,2s,5r)-5-[methyl(propan-2-yl)amino]-2-[(3s)-2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide Chemical compound CC(=O)N[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1C(=O)[C@@H](NC=2C3=CC(=CC=C3N=CN=2)C(F)(F)F)CC1 GVOISEJVFFIGQE-YCZSINBZSA-N 0.000 description 1
RCSBCWXPGSPJNF-UHFFFAOYSA-N n-[4-[5-[3-chloro-4-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]butyl]-4-(1,8-naphthyridin-2-yl)butanamide Chemical compound C1=C(Cl)C(OC(F)(F)F)=CC=C1C(O1)=NN=C1CCCCNC(=O)CCCC1=CC=C(C=CC=N2)C2=N1 RCSBCWXPGSPJNF-UHFFFAOYSA-N 0.000 description 1
PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical class C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
230000000701 neuroleptic effect Effects 0.000 description 1
238000006386 neutralization reaction Methods 0.000 description 1
150000002823 nitrates Chemical class 0.000 description 1
239000012299 nitrogen atmosphere Substances 0.000 description 1
239000010502 orange oil Substances 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
150000003891 oxalate salts Chemical class 0.000 description 1
229910003445 palladium oxide Inorganic materials 0.000 description 1
JQPTYAILLJKUCY-UHFFFAOYSA-N palladium(ii) oxide Chemical compound [O-2].[Pd+2] JQPTYAILLJKUCY-UHFFFAOYSA-N 0.000 description 1
235000021317 phosphate Nutrition 0.000 description 1
150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical class OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
APQPPWOSXDULBB-UHFFFAOYSA-N piperidin-2-one;hydrate Chemical compound O.O=C1CCCCN1 APQPPWOSXDULBB-UHFFFAOYSA-N 0.000 description 1
XIMLAVRHZBUYBE-UHFFFAOYSA-N piperidin-2-one;hydrate;hydrochloride Chemical compound O.Cl.O=C1CCCCN1 XIMLAVRHZBUYBE-UHFFFAOYSA-N 0.000 description 1
239000002798 polar solvent Substances 0.000 description 1
229920000223 polyglycerol Polymers 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
229910000160 potassium phosphate Inorganic materials 0.000 description 1
235000011009 potassium phosphates Nutrition 0.000 description 1
229920001592 potato starch Polymers 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
230000002265 prevention Effects 0.000 description 1
239000000047 product Substances 0.000 description 1
BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
238000000746 purification Methods 0.000 description 1
150000005255 pyrrolopyridines Chemical class 0.000 description 1
239000012429 reaction media Substances 0.000 description 1
150000003873 salicylate salts Chemical class 0.000 description 1
201000000980 schizophrenia Diseases 0.000 description 1
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
239000012312 sodium hydride Substances 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
239000007858 starting material Substances 0.000 description 1
238000003756 stirring Methods 0.000 description 1
239000000758 substrate Substances 0.000 description 1
150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
239000000829 suppository Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
239000003826 tablet Substances 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
235000012222 talc Nutrition 0.000 description 1
150000003892 tartrate salts Chemical class 0.000 description 1
LBLYYCQCTBFVLH-UHFFFAOYSA-M toluenesulfonate group Chemical group C=1(C(=CC=CC1)S(=O)(=O)[O-])C LBLYYCQCTBFVLH-UHFFFAOYSA-M 0.000 description 1
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
230000004580 weight loss Effects 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Child & Adolescent Psychology (AREA)
Pain & Pain Management (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Plural Heterocyclic Compounds (AREA)
Pyrrole Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Pyridine Compounds (AREA)

IL9304190A 1989-01-20 1990-01-12 3-) 1,2,5,6-Tetrahydropyrid-4 il (- H1 Pyrolopyridines and medicinal preparations containing them IL93041A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US1989/000231 WO1990007926A1 (en)	1989-01-20	1989-01-20	3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridines

Publications (2)

Publication Number	Publication Date
IL93041A0 IL93041A0 (en)	1990-11-05
IL93041A true IL93041A (en)	1994-02-27

Family

ID=22214793

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL9304190A IL93041A (en)	1989-01-20	1990-01-12	3-) 1,2,5,6-Tetrahydropyrid-4 il (- H1 Pyrolopyridines and medicinal preparations containing them

Country Status (26)

Country	Link
US (2)	US5051412A (sv)
EP (1)	EP0379314B1 (sv)
JP (1)	JPH0751576B2 (sv)
KR (1)	KR920010642B1 (sv)
CN (1)	CN1025998C (sv)
AT (1)	ATE103282T1 (sv)
CA (1)	CA2008016A1 (sv)
CS (1)	CS277611B6 (sv)
DD (2)	DD298398A5 (sv)
DE (1)	DE69007501T2 (sv)
DK (1)	DK0379314T3 (sv)
EG (1)	EG18945A (sv)
ES (1)	ES2062319T3 (sv)
FI (1)	FI94641C (sv)
HU (1)	HU206349B (sv)
IE (1)	IE62757B1 (sv)
IL (1)	IL93041A (sv)
MX (1)	MX19185A (sv)
MY (1)	MY106305A (sv)
NO (1)	NO912860D0 (sv)
NZ (1)	NZ232166A (sv)
PL (2)	PL163626B1 (sv)
PT (1)	PT92889A (sv)
WO (1)	WO1990007926A1 (sv)
YU (1)	YU47553B (sv)
ZA (1)	ZA90393B (sv)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX19185A (es) *	1989-01-20	1993-12-01	Pfizer	Procedimiento para preparar 3-(1,2,5,6-tretrahidropiridil)-pirrolopiridinas.
US5451566A (en) *	1993-11-17	1995-09-19	Zeneca Limited	Herbicidal pyrrolopyridine compounds
US6586458B1 (en)	1996-08-16	2003-07-01	Pozen Inc.	Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
ZA979961B (en) *	1996-11-15	1999-05-05	Lilly Co Eli	5-HT1F agonists
EP1082958A3 (en) *	1996-11-15	2002-12-11	Eli Lilly And Company	5-HT1F agonists in chronic pain
EP0875513A1 (en) *	1997-04-14	1998-11-04	Eli Lilly And Company	Substituted heteroaromatic 5-HT 1F agonists
US5905084A (en) *	1997-11-14	1999-05-18	Eli Lilly And Company	5-HTIF -agonists effective in treating migraine
ZA989389B (en) *	1997-11-14	2000-04-14	Lilly Co Eli	Pyrrolo [3,2-b] pyridine processes and intermediates.
US6476034B2 (en)	2000-02-22	2002-11-05	Bristol-Myers Squibb Company	Antiviral azaindole derivatives
PT1575566E (pt)	2002-12-26	2012-03-29	Pozen Inc	Formas de dosagem em multicamada contendo naproxeno e triptanos
US20050130954A1 (en) *	2003-11-21	2005-06-16	Mitchell Ian S.	AKT protein kinase inhibitors
US7361763B2 (en) *	2004-07-27	2008-04-22	Sgx Pharmaceuticals, Inc.	Pyrrolo-pyridine kinase modulators
US7361764B2 (en)	2004-07-27	2008-04-22	Sgx Pharmaceuticals, Inc.	Pyrrolo-pyridine kinase modulators
WO2006015124A2 (en)	2004-07-27	2006-02-09	Sgx Pharmaceuticals, Inc.	Fused ring heterocycle kinase modulators
US7626021B2 (en) *	2004-07-27	2009-12-01	Sgx Pharmaceuticals, Inc.	Fused ring heterocycle kinase modulators
US20060100432A1 (en)	2004-11-09	2006-05-11	Matiskella John D	Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US7851476B2 (en)	2005-12-14	2010-12-14	Bristol-Myers Squibb Company	Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine
US7807671B2 (en)	2006-04-25	2010-10-05	Bristol-Myers Squibb Company	Diketo-piperazine and piperidine derivatives as antiviral agents
MX2008016203A (es)	2006-07-06	2009-01-27	Array Biopharma Inc	Ciclopenta [d] pirimidinas como inhibidores de la proteina cinasa akt.
US8063050B2 (en)	2006-07-06	2011-11-22	Array Biopharma Inc.	Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
DE602007011628D1 (de)	2006-07-06	2011-02-10	Array Biopharma Inc	Dihydrofuropyrimidine als akt-proteinkinaseinhibitoren
JP5231411B2 (ja)	2006-07-06	2013-07-10	アレイバイオファーマ、インコーポレイテッド	Ａｋｔプロテインキナーゼ阻害剤としてのジヒドロチエノピリミジン
EP2114955B1 (en) *	2006-12-29	2013-02-13	Rigel Pharmaceuticals, Inc.	Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
US8846683B2 (en)	2007-07-05	2014-09-30	Array Biopharma, Inc.	Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
CA2692502C (en)	2007-07-05	2016-03-01	Array Biopharma Inc.	Pyrimidyl cyclopentanes as akt protein kinase inhibitors
KR101624361B1 (ko) *	2007-07-05	2016-05-25	어레이 바이오파마 인크.	Ａｋｔ 단백질 키나제 억제제로서의 피리미딜 시클로펜탄
US9409886B2 (en)	2007-07-05	2016-08-09	Array Biopharma Inc.	Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
EP2247578B1 (en) *	2008-01-09	2013-05-22	Array Biopharma, Inc.	Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
NZ586720A (en) *	2008-01-09	2012-11-30	Array Biopharma Inc	Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor
ES2528032T3 (es)	2009-01-16	2015-02-03	Rigel Pharmaceuticals, Inc.	Inhibidores de Axl para su uso en terapia de combinación para prevenir, tratar o manejar cáncer metastásico
UY32717A (es)	2009-06-17	2011-01-31	Vertex Pharma	Inhibidores de la replicación de virus de la gripe
WO2012083117A1 (en)	2010-12-16	2012-06-21	Vertex Pharmaceuticals Incorporated	Inhibitors of influenza viruses replication
BR112013025397A2 (pt)	2011-04-01	2019-09-24	Deepak Sampath	combinação de um composto, composto de fórmula i ou um sal farmaceuticamente aceitável do mesmo, uso, kit, produto, método para tratamento de um distúrbio hiperproliferativo e método para tratamento de uma doença ou afecção modulada por quinase akt em um mamífero
MY179607A (en)	2011-04-01	2020-11-11	Genentech Inc	Combinations of akt inhibitor compounds and abiraterone, and methods of use
UA118010C2 (uk)	2011-08-01	2018-11-12	Вертекс Фармасьютікалз Інкорпорейтед	Інгібітори реплікації вірусів грипу
JP6440625B2 (ja)	2012-11-14	2018-12-19	ザ・ジョンズ・ホプキンス・ユニバーシティー	精神分裂病を処置するための方法および組成物
EP3578554A1 (en)	2013-11-13	2019-12-11	Vertex Pharmaceuticals Incorporated	Inhibitors of influenza viruses replication
LT3421468T (lt)	2013-11-13	2021-01-11	Vertex Pharmaceuticals Incorporated	Gripo virusų replikacijos inhibitorių paruošimo būdai
MX371151B (es)	2014-10-23	2020-01-20	Janssen Pharmaceutica Nv	NUEVOS DERIVADOS DE TIENOPIRIMIDINA EN CALIDAD DE INHIBIDORES DE LA CINASA INDUCTORA DE NF-kB (NIK).
BR112017007704B1 (pt) *	2014-10-23	2023-04-11	Janssen Pharmaceutica N.V	Derivados de pirazolopirimidina como inibidores de nik, seu uso e composição farmacêutica que os compreende
JP6857617B2 (ja)	2015-05-13	2021-04-14	バーテックスファーマシューティカルズインコーポレイテッドＶｅｒｔｅｘＰｈａｒｍａｃｅｕｔｉｃａｌｓＩｎｃｏｒｐｏｒａｔｅｄ	インフルエンザウイルスの複製の阻害剤
WO2016183116A1 (en)	2015-05-13	2016-11-17	Vertex Pharmaceuticals Incorporated	Methods of preparing inhibitors of influenza viruses replication

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3272804A (en) *	1963-12-23	1966-09-13	Sterling Drug Inc	Process and intermediates for preparing indoles
GB1141949A (en) *	1966-02-23	1969-02-05	Sterling Drug Inc	7-azaindole derivatives
IL48508A (en) *	1974-12-09	1979-10-31	Roussel Uclaf	Pharmaceutical compositions comprising piperidylindole derivatives
FR2362628A1 (fr) *	1976-08-26	1978-03-24	Roussel Uclaf	Nouveaux derives du piperidyl-indole et leurs sels, procede de preparation et application a titre de medicaments
FR2421899A1 (fr) *	1978-01-16	1979-11-02	Roussel Uclaf	Nouveaux derives du tetrahydropyridinyl-indole et leurs sels, le procede de preparation et l'application a titre de medicaments de ces nouveaux produits
FR2444678A2 (fr) *	1978-12-22	1980-07-18	Roussel Uclaf	Nouveau procede de preparation de derives du piperidyl-indole et de leurs sels
US5025096A (en) *	1985-08-22	1991-06-18	Mine Safety Appliances Company	Preparation of indole and indole derivatives
MX19185A (es) *	1989-01-20	1993-12-01	Pfizer	Procedimiento para preparar 3-(1,2,5,6-tretrahidropiridil)-pirrolopiridinas.

1989
- 1989-01-20 MX MX1918590A patent/MX19185A/es unknown
- 1989-01-20 WO PCT/US1989/000231 patent/WO1990007926A1/en not_active Ceased
- 1989-01-23 US US07/576,429 patent/US5051412A/en not_active Expired - Lifetime
- 1989-01-23 HU HU9249A patent/HU206349B/hu not_active IP Right Cessation
1990
- 1990-01-12 DK DK90300361.4T patent/DK0379314T3/da active
- 1990-01-12 ES ES90300361T patent/ES2062319T3/es not_active Expired - Lifetime
- 1990-01-12 AT AT90300361T patent/ATE103282T1/de active
- 1990-01-12 IL IL9304190A patent/IL93041A/en not_active IP Right Cessation
- 1990-01-12 DE DE69007501T patent/DE69007501T2/de not_active Expired - Fee Related
- 1990-01-12 EP EP90300361A patent/EP0379314B1/en not_active Expired - Lifetime
- 1990-01-17 EG EG2690A patent/EG18945A/xx active
- 1990-01-17 MY MYPI90000082A patent/MY106305A/en unknown
- 1990-01-18 PT PT92889A patent/PT92889A/pt unknown
- 1990-01-18 CS CS90260A patent/CS277611B6/cs not_active IP Right Cessation
- 1990-01-18 CA CA002008016A patent/CA2008016A1/en not_active Abandoned
- 1990-01-19 JP JP2010431A patent/JPH0751576B2/ja not_active Expired - Lifetime
- 1990-01-19 IE IE21090A patent/IE62757B1/en not_active IP Right Cessation
- 1990-01-19 CN CN90100888A patent/CN1025998C/zh not_active Expired - Fee Related
- 1990-01-19 DD DD90343473A patent/DD298398A5/de not_active IP Right Cessation
- 1990-01-19 KR KR1019900000626A patent/KR920010642B1/ko not_active Expired
- 1990-01-19 DD DD90337216A patent/DD291559A5/de not_active IP Right Cessation
- 1990-01-19 PL PL90283354A patent/PL163626B1/pl unknown
- 1990-01-19 PL PL28784090A patent/PL287840A1/xx unknown
- 1990-01-19 ZA ZA90393A patent/ZA90393B/xx unknown
- 1990-01-19 YU YU9990A patent/YU47553B/sh unknown
- 1990-01-19 NZ NZ232166A patent/NZ232166A/en unknown
1991
- 1991-07-22 FI FI913509A patent/FI94641C/sv not_active IP Right Cessation
- 1991-07-22 NO NO1991912860A patent/NO912860D0/no unknown
- 1991-09-20 US US07/763,081 patent/US5169947A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
ATE103282T1 (de)	1994-04-15
HUT57762A (en)	1991-12-30
PL283354A1 (en)	1991-08-12
IE62757B1 (en)	1995-02-22
US5051412A (en)	1991-09-24
IE900210L (en)	1990-07-23
EG18945A (en)	1994-09-29
CA2008016A1 (en)	1990-07-20
HU206349B (en)	1992-10-28
WO1990007926A1 (en)	1990-07-26
KR920010642B1 (ko)	1992-12-12
DD291559A5 (de)	1991-07-04
CS277611B6 (en)	1993-03-17
EP0379314B1 (en)	1994-03-23
ES2062319T3 (es)	1994-12-16
JPH02247175A (ja)	1990-10-02
FI913509A0 (sv)	1991-07-22
FI94641B (sv)	1995-06-30
KR900011772A (ko)	1990-08-02
DD298398A5 (de)	1992-02-20
FI94641C (sv)	1995-10-10
MX19185A (es)	1993-12-01
DK0379314T3 (da)	1994-05-09
IL93041A0 (en)	1990-11-05
MY106305A (en)	1995-04-29
CS26090A3 (en)	1992-02-19
PT92889A (pt)	1990-07-31
YU47553B (sh)	1995-10-03
ZA90393B (en)	1991-08-28
AU4867390A (en)	1990-07-26
US5169947A (en)	1992-12-08
NZ232166A (en)	1992-10-28
CN1025998C (zh)	1994-09-28
EP0379314A1 (en)	1990-07-25
DE69007501T2 (de)	1994-06-30
PL163626B1 (pl)	1994-04-29
CN1044465A (zh)	1990-08-08
NO912860L (no)	1991-07-22
DE69007501D1 (de)	1994-04-28
NO912860D0 (no)	1991-07-22
AU613259B2 (en)	1991-07-25
JPH0751576B2 (ja)	1995-06-05
YU9990A (en)	1992-05-28
PL287840A1 (en)	1991-07-15

Publication	Publication Date	Title
EP0379314B1 (en)	1994-03-23	3-(1,2,5,6-Tetrahydropyridyl)-pyrrolopyridines
JP4796698B2 (ja)	2011-10-19	新たな薬学的に活性な化合物
AU669520B2 (en)	1996-06-13	Pyrido(2,3-d)pyrimidine derivatives as phosphodiesterase inhibitors
EP2041133B1 (fr)	2010-10-13	Dérivés d'imidazo[1,2-a]pyridine-2-carboxamides leur préparation et leur application en thérapeutique
AU2012301953B2 (en)	2016-05-12	Antibacterial compounds and methods for use
EA020409B1 (ru)	2014-10-30	Антагонисты рецептора cgrp
MXPA01010915A (es)	2002-11-07	Esteroides sustituidos con 3alfa-hidroxi-3beta mexoximetil- 21 -heterociclo, con actividad anestesica.
CN117143107A (zh)	2023-12-01	1,2-二氢吡啶类衍生物及其制备方法和用途
EP1919872A2 (en)	2008-05-14	Chemical compounds
RU2093513C1 (ru)	1997-10-20	Производные 9-деазагуанины или их таутомеры и фармацевтическая композиция, обладающая способностью ингибировать активность пуриннуклеозид фосфорилазы у млекопитающих
IE58115B1 (en)	1993-07-14	New beta -carboline-3-oxadiazolyl derivatives,method of preparing the same and their use
EP1904501A2 (en)	2008-04-02	Chemical compounds
KR20010005676A (ko)	2001-01-15	테트라히드로피리도 화합물
CA1264748A (en)	1990-01-23	.beta.-carboline-3-oxadiazolyl derivatives, method of preparing the same and_their use
CN111278814A (zh)	2020-06-12	作为毒蕈碱m1受体正向别构调节剂的多环酰胺
US5407940A (en)	1995-04-18	New ellipticine compounds
HK1010051B (en)	1999-06-11	Ellipticine derivatives with antitumor activity
JP3545332B2 (ja)	2004-07-21	新規カンプトテシン類似化合物、それらの製造方法、及びそれらを含有する医薬組成物
HK40022741A (en)	2020-11-20	Polycyclic amides as muscarinic m1 receptor positive allosteric modulators
FR2486801A1 (fr)	1982-01-22	Compositions pharmaceutiques a base de pyridoindoles
NZ623063B2 (en)	2016-08-02	Antibacterial compounds and methods for use

Legal Events

Date	Code	Title	Description
1996-10-31	RH	Patent void